These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1523589)

  • 1. [Contribution of data of efficacy trials to judge the improvement of the medical usefulness of a drug].
    Bouvenot G; Eschwège E
    Therapie; 1992; 47(1):17-9. PubMed ID: 1523589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices on trial, Part I.
    Wright D
    Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing face of clinical trials.
    Kitler ME
    J Hypertens Suppl; 1988 Nov; 6(1):S73-80. PubMed ID: 3063796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmarketing studies of drug efficacy.
    Strom BL; Melmon KL; Miettinen OS
    Arch Intern Med; 1985 Oct; 145(10):1791-4. PubMed ID: 3899034
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmarketing surveillance versus clinical trials: which benefits the patient?
    Lawson DH
    Cardiology; 1994; 85 Suppl 1():18-23. PubMed ID: 7743530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of events associated with drugs: regulatory perspectives.
    Jones JK
    J Rheumatol Suppl; 1988 Oct; 17():14-9. PubMed ID: 3204615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial--observation studies in general practice].
    Kleinsorge H
    Verh Dtsch Ges Inn Med; 1988; 94():431-6. PubMed ID: 3061215
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary drug-eluting stent development: issues in trial design.
    Muni NI; Califf RM; Foy JR; Boam AB; Zuckerman BD; Kuntz RE
    Am Heart J; 2005 Mar; 149(3):415-33. PubMed ID: 15864230
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proposal of guidelines for the set-up of pharmaco-epidemiologic studies in drug surveillance].
    de Tricornot B; Saddier P; Bons B; Clément JP; Courtand M; Lamarque V; Thomas A; Tomczyk S; Vaissère J
    Therapie; 1997; 52(6):579-85. PubMed ID: 9734111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety in clinical trials.
    Wallander MA
    Scand J Prim Health Care Suppl; 1990; 1():89-91. PubMed ID: 2100372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the medical value of a drug. A necessity for the Transparency Commission].
    Avouac B
    Therapie; 1992; 47(1):9-16. PubMed ID: 1523604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for human data: the role of clinical trials and postmarketing surveillance in the safety assessment of macronutrient substitutes.
    Forbes AL
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S20-1; discussion S31-7. PubMed ID: 8801611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based medicine and drug-eluting stents.
    O'Dwyer J
    Med Device Technol; 2004 May; 15(4):34-7. PubMed ID: 15303564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pipeline pharmacogenetics: a novel approach to integrating pharmaco-genetics into drug development.
    Akkari PA; Swanson TW; Crenshaw DG; Grossman I; Sundseth S; Burns DK; Roses AD
    Curr Pharm Des; 2009; 15(32):3754-63. PubMed ID: 19925426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-marketing drug surveillance--concepts, insights and applications.
    Fassihi AR; Robertson SS
    S Afr Med J; 1990 Jun; 77(11):577-80. PubMed ID: 2189230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The safety of drugs].
    de Cea Lavech de Chancy H
    Rev Clin Esp; 1990 Sep; 187(4):184-90. PubMed ID: 2091076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.